Treatment of type 2 diabetic patients with kidney disease with AT_1-receptor antagonists : lessons from recent trials
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-12-01
著者
-
Wieland Kenneth
Merck & Co. Inc.
-
Lyle Paulette
Merck & Co. Inc.
-
Kurokawa K
Research Center For Advanced Science And Technology Of The University Of Tokyo
-
KUROKAWA Kiyoshi
Institute of Medical Sciences, Tokai University School of Medicine
-
KEANE William
Merck & Co., Inc.
-
SHAHINFAR Shahnaz
Merck & Co., Inc.
-
SMITH Thomas
Merck & Co., Inc.
-
BRENNER Barry
Department of Medicine, Renal Division, Brigham and Women's Hospital and Harvard Medical School
-
Brenner Barry
Department Of Medicine Renal Division Brigham And Women's Hospital And Harvard Medical School
-
Smith Thomas
Merck & Co. Inc.
-
Keane William
Merck & Co. Inc.
-
KUROKAWA Kiyoshi
Research Center for Advanced Science and Technology of the University of Tokyo
-
Shahinfar Shahnaz
Merck & Co. Inc.
-
Kurokawa Kiyoshi
Institute Of Medical Sciences Tokai University
関連論文
- Intestinal bacteria-derived putrefactants in chronic renal failure
- Menatetrenone Ameliorates Reduction in Bone Mineral Density and Bone Strength in Sciatic Neurectomized Rats
- Combination use of vitamin K_2 further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats
- Menatetrenone Prevents Osteoblast Dysfunction in Unilateral Sciatic Neurectomized Rats
- Maintenance of trabecular structure and bone volume by vitamin K_2 in mature rats with long-term tail suspension
- Mesangial cell-predominant functional gene, megsin
- Treatment of type 2 diabetic patients with kidney disease with AT_1-receptor antagonists : lessons from recent trials
- A Detective Story for Biomedical Footprints towards New Therapeutic Interventions in Diabetic Nephropathy
- Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes : a subanalysis of Japanese patients from the RENAAL study
- Teaching and Learning Ethical Issues in Medical Education